Selected article for: "adverse outcome independent predictor and disease severity"
Author: Xiaomin Luo; Wei Zhou; Xiaojie Yan; Tangxi Guo; Benchao Wang; Hongxia Xia; Lu Ye; Jun Xiong; Zongping Jiang; Yu Liu; Bicheng Zhang; Weize Yang
Title: Prognostic value of C-reactive protein in patients with COVID-19
  • Document date: 2020_3_23
    • ID: m76ic66s_25
    Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint and multiple organ damage. 14 Recently, a prospective study suggested NLR an early predictor of COVID-19 progressive to severe illness, however, the power of NLR in outcome prediction was not determined due to no follow-up of final outcome. 15 In this retrospective study, raised NLR was found in non-survivors compared to survivors and associated with disease severity on a.....
    Document: is the (which was not peer-reviewed) The copyright holder for this preprint and multiple organ damage. 14 Recently, a prospective study suggested NLR an early predictor of COVID-19 progressive to severe illness, however, the power of NLR in outcome prediction was not determined due to no follow-up of final outcome. 15 In this retrospective study, raised NLR was found in non-survivors compared to survivors and associated with disease severity on admission. However, results of multivariate logistical regression revealed that neither lymphocyte count nor NLR was an independent predictor of adverse outcome or discriminator of severe/critical illness.

    Search related documents:
    Co phrase search for related documents
    • admission disease severity and disease severity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • admission disease severity and independent predictor: 1, 2, 3, 4, 5, 6, 7
    • admission disease severity and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • admission disease severity and multiple organ: 1, 2, 3, 4
    • admission disease severity and NLR lymphocyte count: 1, 2, 3, 4, 5
    • adverse outcome and disease severity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adverse outcome and early predictor: 1
    • adverse outcome and final outcome: 1
    • adverse outcome and independent predictor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • adverse outcome and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • adverse outcome and multiple organ: 1, 2, 3, 4
    • adverse outcome and multiple organ damage: 1
    • adverse outcome and NLR lymphocyte count: 1, 2, 3
    • adverse outcome independent predictor and disease severity: 1, 2
    • adverse outcome independent predictor and early predictor: 1
    • adverse outcome independent predictor and independent predictor: 1, 2, 3, 4, 5, 6
    • adverse outcome independent predictor and lymphocyte count: 1, 2
    • adverse outcome independent predictor and NLR lymphocyte count: 1
    • disease severity and early predictor: 1, 2, 3, 4, 5